Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Applying a Computer-Based Warfarin Management System at a Large Tertiary Cardiovascular Center in Iran Publisher Pubmed



Barati S1 ; Mehdi Mohammadpour M2 ; Ali Sadrameli M1 ; Hosseini S3 ; Maleki M1 ; Golpira R1 ; Bakhshandeh H1 ; Kyavar M1 ; Moosavi J1 ; Mohebbi B1 ; Talasaz AH4 ; Barco S5, 6 ; Klok FA6, 7 ; Sadeghipour P1
Authors
Show Affiliations
Authors Affiliations
  1. 1. The Rajaie Cardiovascular Medical and Research Center, Iran University of Medical Sciences, Tehran, Iran
  2. 2. School of Technology, SRH Berlin University of Applied Science, Berlin, Germany
  3. 3. Heart Valve Diseases Research Center, Rajaie Cardiovascular, Medical, and Research Center, Iran University of Medical Sciences, Tehran, Iran
  4. 4. Tehran Heart Center, Tehran University of Medical Sciences, Tehran, Iran
  5. 5. Department of Angiology, University Hospital Zurich, Zurich, Switzerland
  6. 6. Center for Thrombosis and Hemostasis, Johannes Gutenberg University Mainz, Mainz, Germany
  7. 7. Department of Medicine-Thrombosis and Hemostasis, Leiden University Medical Center, Leiden, Netherlands

Source: Critical Pathways in Cardiology Published:2024


Abstract

Background: Regarding adjustments to warfarin dosage, numerous studies have shown that computerized methods are superior to those based on personal experience. Objectives: To report the efficacy of a computer-based warfarin management system (WMS) in the Iranian population. Methods: By utilizing the existing dosing algorithms and obtaining expert opinions, we developed a computer-based WMS at a large tertiary cardiovascular center. The time in therapeutic range and the number of international normalized ratio (INR) tests of clinic patients were compared before and after the implementation of WMS. Results: Overall, 803 patients with 5407 INR tests were included in the before phase and 679 patients with 4189 INR tests in the after phase. The mean time in therapeutic range was 57.3% before and 59% after WMS implementation [mean difference, 1.64; 95% confidence interval (CI), −1.12–4.40]. In the before phase, the mean number of INR tests was 6.7, which dropped to 6.1 tests in the after phase (mean difference, −0.61; 95% CI, −0.97 to −0.24). Only 54.5% of the warfarin dosing prescriptions were consistent with the dosing recommendations of the WMS, and adherence to the WMS was poorest in the highest INR target range. Conclusions: For the first time in Iran, we demonstrated that a computerized system was as effective as a traditional experience-based method to monitor INR in VKA-anticoagulated patients. Furthermore, it could reduce both the number of INR tests and that of visits. Copyright © 2024 Wolters Kluwer Health, Inc. All rights reserved.
Related Docs
Experts (# of related papers)